An app being made by DeepMind, the Google-owned AI company, working in collaboration with the NHS Royal Free Trust in London and being used to help identify hospital patients who might be at risk of acute kidney disease (AKI) is not currently in use, TechCrunch has learned. Read More
from Google – TechCrunch http://ift.tt/1XziLss
No comments:
Post a Comment